24
Feb 2026
Moderate physical activity lowers risk of sarcopenic obesity in seniors
Older people who are physically active have a significantly lower risk of developing sarcopenic obesity - a combination of obesity and weak muscles.
Stay Informed!
24
Feb 2026
Modified Clostridium sporogenes shows promise in targeting solid tumors
A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumors from the inside out.
24
Feb 2026
Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants.
24
Feb 2026
Advantech highlights real-time medical edge AI at HIMSS 2026
Advantech, a global leader in embedded and Internet of Things (IoT) solutions, will showcase its latest healthcare AI innovations at the HIMSS 2026 Global Health Conference & Exhibition, March 9–12, 2026, in Las Vegas, Nevada.
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg "SwRI advances safer manufacturing of nerve agent antidotes")
24
Feb 2026
SwRI advances safer manufacturing of nerve agent antidotes
Southwest Research Institute (SwRI) continues to expand its unique drug synthesis capabilities and expertise to advance the scalable manufacturing of safer antidotes to combat exposure to organophosphorus nerve agents (OPNAs) and pesticides.
23
Feb 2026
Assessing long-term cognitive risks in ependymoma survivors
A study led by St. Jude Children's Research Hospital assessed cognitive and communication abilities in children treated for the brain tumor ependymoma to understand the impact of treatment better. They found that radiation was a significant contributor to hearing loss, a risk directly linked to cognitive health.
23
Feb 2026
New EANM award supports alpha radioligand therapy research
Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative research in alpha radioligand therapy (α-RLT) in prostate cancer.
23
Feb 2026
UCLA Health finds eco-friendly inhalers improve COPD outcomes
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly better patient outcomes. Inhalers are essential therapies for COPD and other lung conditions, but many commonly used devices rely on propellants that are potent greenhouse gases.
23
Feb 2026
AI model forecasts bone removal in cochlear implant surgery
Cochlear implant surgery helps people with severe hearing loss by placing an electronic device inside the inner ear. To reach the inner ear, surgeons must first remove part of a bone behind the ear, in a procedure called mastoidectomy.
23
Feb 2026
The gender gap in early Lyme disease detection and signs
In a new Johns Hopkins Medicine study, researchers found that male and female patients with early Lyme disease present with different signs of the disease in the symptoms they report, their physical exams, and their laboratory test results.
